Egypt Pharmaceutical Market to be Dominated by Target Therapy Through 2028
The increasing demand for colored pharmaceuticals as a
fashion accessory is expected to drive the growth of the Egypt Pharmaceutical market
during the forecast period, 2024-2028.
According to the TechSci
Research report, “Egypt Pharmaceutical Market - By
Region, Competition, Forecast and Opportunities, 2028” Egypt Pharmaceutical
Market is projected to increase at an impressive rate during the forecast
period, 2024-2028. The factors responsible for the growth of the market are the
increasing prevalence of chronic diseases in Egypt, along with rising research
and development in pharmaceuticals. Furthermore, the development of personalized
medicines in the market is anticipated to fuel the pharmaceutical market
expansion throughout the forecast period. Moreover, the rising elderly population
with various communicable diseases such as tropical and vector borne diseases, tuberculosis,
coronavirus infections, dengue, hepatitis along with non-communicable diseases
such as cardiovascular diseases., cancers, diabetes, chronic
respiratory diseases. is anticipated to support the growth of the market during
the forecast period.
However, factors hampering
the overall growth of the Egypt pharmaceutical market are stringent regulation
along with delayers regulatory approvals. Moreover, absence of technical
support miscommunication between governmental and pharmaceutical regulatory
affairs, the gap between academia and industry, and regulatory, developmental,
and manufacturing challenges beginning with product registration are limiting
the growth of the market.
Browse over XX market
data Figures spread through 70 Pages and an in-depth TOC on the "Egypt Pharmaceutical Market”
Egypt pharmaceutical
market is segmented on the basis of type, drug classification, mode of purchase,
and distribution channels.
Based on type,
the market is further divided into pharmaceutical drugs and biologics. Pharmaceutical
drugs is expected to increase at a high CAGR in the Egypt Pharmaceutical market.
The demand for medicines due to increasing chronic diseases is expected to fuel
market expansion. Moreover, Monoclonal Antibodies (MAbS) and Therapeutic
Proteins, Vaccines are anticipated to support the growth of the market
throughout the forecast period, 2024-2028.
Based on drug
classification the market is segmented into branded drugs and generic drugs.
The generic drugs segment is expected to drive the growth of the market
throughout the forecast period, 2024-2028. The primary reason fueling this
market's growth is the rapid patent expiration of branded medications. Diabetes
and cardiovascular disorders, which are becoming more common, are also
anticipated to hasten the market's total expansion. Further, increased
spending on intensive research and development projects as well as formulation
innovations such fixed dose combinations and cost-effective treatments are also
anticipated to temper market expansion. Additionally, it is predicted that the
numerous licensing and partnering techniques used by major vendors to introduce
new products, which will create lucrative prospects for the market. The
preference for less expensive solutions in recent government reimbursement
systems will increase the growth pace of the generic medication market in the
future.
Based on the mode
of purchase, the market is further divided into prescription-based drugs, and over-the-counter
drugs. The prescription-based drugs segment is expected to hold the largest
market share during the forecast period, 2024-2028. Numerous vaccines and
treatments for acute and chronic illnesses are included in prescription drugs.
These conditions include diabetes, cancer, cardiovascular disease, and orphan
diseases. Effective prescription drug administration is essential in today's
therapeutic environment for enhancing clinical outcomes for virtually every
patient suffering from serious disorders.
Major
companies operating in the Egypt Pharmaceutical Market are:
- MDI Pharma
- Merck & Co.
- Novartis AG
- Pharco
Pharmaceuticals
- Roche Holding AG
- Sanofi S.A
- EVA Pharma
- Orchidia
Pharmaceutical Industries
- GlaxoSmithKline
- Tabuk
Pharmaceuticals
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
Based on distribution channels, the
market is further divided into hospital pharmacies, retail pharmacies, and online
pharmacies. One of the main factors contributing to hospital pharmacies'
domination in the market is the fact that the therapies listed under
prescription pharmaceuticals are frequently only able to be prescribed in
hospital settings under the supervision of qualified medical personnel.
Additionally, a variety of medications used to treat serious illnesses
including cancer and orphan diseases can only be given intravenously by
qualified medical personnel. Clinical outcomes are frequently improved as a
result of the right treatment and management of important diseases made
possible by such excellent therapeutic administration.”
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based Egypt management consulting firm.
Egypt Pharmaceutical Market- Type{Pharmaceutical Drugs (Gynecology Drugs, Respiratory
Drugs, Dermatology Drugs, Analgesic Drugs, Oncology Drugs, Others) and
Biologics (Monoclonal Antibodies (MAbS, Therapeutic Proteins, Vaccines)}, By
Drug Classification (Branded Drugs v/s Generic Drugs), By Mode of Purchase
(Prescription-Based Drugs v/s Over-the-counter Drugs), By Distribution Channel
(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company and By
Region,
has evaluated the future growth potential of Egypt Pharmaceutical Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision-makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in the Egypt Pharmaceutical Market.”
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com